Cargando…
Real world study for the concordance between IBM Watson for Oncology and clinical practice in advanced non‐small cell lung cancer patients at a lung cancer center in China
BACKGROUND: IBM Watson for Oncology (WFO) provides physicians with evidence‐based treatment options. This study was designed to explore the concordance of the suggested therapeutic regimen for advanced non‐small cell lung (NSCLC) cancer patients between the updated version of WFO and physicians in o...
Autores principales: | Yao, Shuyang, Wang, Ruotian, Qian, Kun, Zhang, Yi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley & Sons Australia, Ltd
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7180560/ https://www.ncbi.nlm.nih.gov/pubmed/32191394 http://dx.doi.org/10.1111/1759-7714.13391 |
Ejemplares similares
-
Concordance Study Between IBM Watson for Oncology and Real Clinical Practice for Cervical Cancer Patients in China: A Retrospective Analysis
por: Zou, Fang-wen, et al.
Publicado: (2020) -
Concordance assessment of Watson for Oncology in breast cancer chemotherapy: first China experience
por: Pan, Hong, et al.
Publicado: (2019) -
Concordance of Treatment Recommendations for Metastatic Non-Small-Cell Lung Cancer Between Watson for Oncology System and Medical Team
por: You, Hai-Sheng, et al.
Publicado: (2020) -
Concordance Between Watson for Oncology and Multidisciplinary Teams in Colorectal Cancer: Prognostic Implications and Predicting Concordance
por: Mao, Chenchen, et al.
Publicado: (2020) -
Concordance Rate between Clinicians and Watson for Oncology among Patients with Advanced Gastric Cancer: Early, Real-World Experience in Korea
por: Choi, Youn I, et al.
Publicado: (2019)